MADRIGAL PHARMACEUTICALS, INC. Operating Expenses
MADRIGAL PHARMACEUTICALS, INC. (MDGL) reported Operating Expenses of $420.56 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-07-30
- MADRIGAL PHARMACEUTICALS, INC. operating expenses for the quarter ending 2026-06-30 was $420.56M, a 61.75% increase year-over-year.
- MADRIGAL PHARMACEUTICALS, INC. operating expenses for the quarter ending 2026-03-31 was $404.06M, a 86.58% increase year-over-year.
- MADRIGAL PHARMACEUTICALS, INC. operating expenses for the quarter ending 2025-12-31 was $380.69M, a 123.52% increase year-over-year.
- MADRIGAL PHARMACEUTICALS, INC. operating expenses for the quarter ending 2025-09-30 was $401.24M, a 124.81% increase year-over-year.
- MADRIGAL PHARMACEUTICALS, INC. operating expenses for fiscal 2025 was $1.26B, a 85.62% increase from fiscal 2024.
- MADRIGAL PHARMACEUTICALS, INC. operating expenses for fiscal 2024 was $678.01M, a 78.19% increase from fiscal 2023.
- MADRIGAL PHARMACEUTICALS, INC. operating expenses for fiscal 2023 was $380.50M, a 29.61% increase from fiscal 2022.
- MADRIGAL PHARMACEUTICALS, INC. operating expenses for fiscal 2022 was $293.57M, a 21.07% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $420.56M 10-Q · filed 2026-07-30 | $824.62M 10-Q · filed 2026-07-30 | $1.21B derived: sum of 3 quarters · filed 2026-07-30 | $1.61B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $404.06M 10-Q · filed 2026-05-06 | $784.75M derived: sum of 2 quarters · filed 2026-05-06 | $1.19B derived: sum of 3 quarters · filed 2026-05-06 | $1.45B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $380.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $781.93M derived: sum of 2 quarters · filed 2026-02-19 | $1.04B derived: sum of 3 quarters · filed 2026-07-30 | $1.26B 10-K · filed 2026-02-19 | ||||
| 2025-09-30 | $401.24M 10-Q · filed 2025-11-04 | $661.25M derived: sum of 2 quarters · filed 2026-07-30 | $877.81M 10-Q · filed 2025-11-04 | $1.05B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $260.00M 10-Q · filed 2026-07-30 | $476.56M 10-Q · filed 2026-07-30 | $646.88M derived: sum of 3 quarters · filed 2026-07-30 | $825.36M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $216.56M 10-Q · filed 2026-05-06 | $386.88M derived: sum of 2 quarters · filed 2026-05-06 | $565.36M derived: sum of 3 quarters · filed 2026-05-06 | $742.53M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $170.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $348.80M derived: sum of 2 quarters · filed 2026-02-19 | $525.97M derived: sum of 3 quarters · filed 2026-02-19 | $678.01M 10-K · filed 2026-02-19 | ||||
| 2024-09-30 | $178.48M 10-Q · filed 2025-11-04 | $355.65M derived: sum of 2 quarters · filed 2025-11-04 | $507.69M 10-Q · filed 2025-11-04 | $624.87M derived: sum of 4 quarters · filed 2025-11-04 | ||||
| 2024-06-30 | $177.18M 10-Q · filed 2025-08-05 | $329.21M 10-Q · filed 2025-08-05 | $446.39M derived: sum of 3 quarters · filed 2025-08-05 | $544.92M derived: sum of 4 quarters · filed 2025-08-05 | ||||
| 2024-03-31 | $152.04M 10-Q · filed 2025-05-01 | $269.21M derived: sum of 2 quarters · filed 2025-05-01 | $367.75M derived: sum of 3 quarters · filed 2025-05-01 | $454.20M derived: sum of 4 quarters · filed 2025-05-01 | ||||
| 2023-12-31 | $117.18M 10-K · filed 2024-02-28 | $215.71M derived: sum of 2 quarters · filed 2024-10-31 | $302.16M derived: sum of 3 quarters · filed 2024-10-31 | $380.50M 10-K · filed 2026-02-19 | ||||
| 2023-09-30 | $98.53M 10-Q · filed 2024-10-31 | $184.98M derived: sum of 2 quarters · filed 2024-10-31 | $263.32M 10-Q · filed 2024-10-31 | $348.62M derived: sum of 4 quarters · filed 2024-10-31 | ||||
| 2023-06-30 | $86.45M 10-Q · filed 2024-08-07 | $164.79M 10-Q · filed 2024-08-07 | $250.09M derived: sum of 3 quarters · filed 2024-08-07 | $330.50M derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2023-03-31 | $78.34M 10-Q · filed 2024-05-07 | $163.63M derived: sum of 2 quarters · filed 2024-05-07 | $244.05M derived: sum of 3 quarters · filed 2024-05-07 | $314.32M derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | $85.30M 10-K · filed 2024-02-28 | $165.71M derived: sum of 2 quarters · filed 2024-02-28 | $235.98M derived: sum of 3 quarters · filed 2024-02-28 | $293.57M 10-K · filed 2024-02-28 | ||||
| 2022-09-30 | $80.41M 10-K · filed 2024-02-28 | $150.69M derived: sum of 2 quarters · filed 2024-02-28 | $208.27M 10-Q · filed 2023-11-06 | $272.87M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-06-30 | $70.27M 10-K · filed 2024-02-28 | $127.86M 10-Q · filed 2023-08-08 | $192.46M derived: sum of 3 quarters · filed 2024-02-28 | $255.62M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-03-31 | $57.59M 10-K · filed 2024-02-28 | $122.19M derived: sum of 2 quarters · filed 2024-02-28 | $185.35M derived: sum of 3 quarters · filed 2024-02-28 | $247.09M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2021-12-31 | $64.60M 10-K/A · filed 2023-03-03 | $127.76M derived: sum of 2 quarters · filed 2023-03-03 | $189.50M derived: sum of 3 quarters · filed 2023-03-03 | $242.48M 10-K · filed 2024-02-28 | ||||
| 2021-09-30 | $63.16M 10-K/A · filed 2023-03-03 | $124.90M derived: sum of 2 quarters · filed 2023-03-03 | $177.88M 10-Q · filed 2022-11-03 | $237.44M derived: sum of 4 quarters · filed 2023-03-03 | ||||
| 2021-06-30 | $61.74M 10-K/A · filed 2023-03-03 | $114.72M 10-Q · filed 2022-08-04 | $174.28M derived: sum of 3 quarters · filed 2023-03-03 | $233.06M derived: sum of 4 quarters · filed 2023-03-03 | ||||
| 2021-03-31 | $52.98M 10-K/A · filed 2023-03-03 | $112.53M derived: sum of 2 quarters · filed 2023-03-03 | $171.32M derived: sum of 3 quarters · filed 2023-03-03 | $221.65M derived: sum of 4 quarters · filed 2023-03-03 | ||||
| 2020-12-31 | $59.55M 10-K · filed 2022-02-24 | $118.34M derived: sum of 2 quarters · filed 2022-02-24 | $168.67M derived: sum of 3 quarters · filed 2022-02-24 | $206.67M 10-K/A · filed 2023-03-03 | ||||
| 2020-09-30 | $58.79M 10-K · filed 2022-02-24 | $109.11M derived: sum of 2 quarters · filed 2022-02-24 | $147.12M 10-Q · filed 2021-11-04 | $177.07M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | $50.33M 10-K · filed 2022-02-24 | $88.33M 10-Q · filed 2021-08-05 | $118.29M derived: sum of 3 quarters · filed 2022-02-24 | $142.48M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | $38.01M 10-K · filed 2022-02-24 | $67.96M derived: sum of 2 quarters · filed 2022-02-24 | $92.15M derived: sum of 3 quarters · filed 2022-02-24 | $114.86M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | $29.95M 10-K · filed 2021-02-25 | $54.15M derived: sum of 2 quarters · filed 2021-02-25 | $76.85M derived: sum of 3 quarters · filed 2021-02-25 | $94.97M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | $24.20M 10-K · filed 2021-02-25 | $46.90M derived: sum of 2 quarters · filed 2021-02-25 | $65.02M 10-Q · filed 2020-11-05 | $79.47M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $22.70M 10-K · filed 2021-02-25 | $40.82M 10-Q · filed 2020-08-06 | $55.28M derived: sum of 3 quarters · filed 2021-02-25 | $66.61M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $18.12M 10-K · filed 2021-02-25 | $32.57M derived: sum of 2 quarters · filed 2021-02-25 | $43.91M derived: sum of 3 quarters · filed 2021-02-25 | $51.73M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $14.45M 10-K · filed 2020-02-26 | $25.79M derived: sum of 2 quarters · filed 2020-02-26 | $33.61M derived: sum of 3 quarters · filed 2020-02-26 | $40.68M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $11.33M 10-K · filed 2020-02-26 | $19.16M derived: sum of 2 quarters · filed 2020-02-26 | $26.23M 10-Q · filed 2019-11-06 | $35.14M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-06-30 | $7.83M 10-K · filed 2020-02-26 | $14.89M 10-Q · filed 2019-08-07 | $23.81M derived: sum of 3 quarters · filed 2020-02-26 | $32.44M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-03-31 | $7.07M 10-K · filed 2020-02-26 | $15.98M derived: sum of 2 quarters · filed 2020-02-26 | $24.62M derived: sum of 3 quarters · filed 2020-02-26 | $33.06M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2017-12-31 | $8.91M 10-K · filed 2019-02-27 | $17.55M derived: sum of 2 quarters · filed 2019-02-27 | $25.99M derived: sum of 3 quarters · filed 2019-02-27 | $32.06M 10-K · filed 2020-02-26 | ||||
| 2017-09-30 | $8.64M 10-K · filed 2019-02-27 | $17.08M derived: sum of 2 quarters · filed 2019-02-27 | $23.15M 10-Q · filed 2018-11-06 | $30.91M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | $8.44M 10-K · filed 2019-02-27 | $14.51M 10-Q · filed 2018-08-07 | $22.27M derived: sum of 3 quarters · filed 2019-02-27 | $36.36M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-03-31 | $6.08M 10-K · filed 2019-02-27 | $13.83M derived: sum of 2 quarters · filed 2019-02-27 | $27.92M derived: sum of 3 quarters · filed 2019-02-27 | $30.56M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | $7.75M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $21.85M derived: sum of 2 quarters · filed 2019-02-27 | $24.48M derived: sum of 3 quarters · filed 2019-02-27 | $25.22M 10-K · filed 2019-02-27 | $25.22M 10-K · filed 2017-03-31 | |||
| 2016-09-30 | $14.09M 10-Q · filed 2017-11-09 | $14.09M 10-Q · filed 2016-11-14 | $16.73M derived: sum of 2 quarters · filed 2017-11-09 | $17.47M 10-Q · filed 2017-11-09 | $17.47M 10-Q · filed 2016-11-14 | $27.85M derived: sum of 4 quarters · filed 2017-11-09 | ||
| 2016-06-30 | $2.64M 10-Q · filed 2017-08-10 | $3.49M 10-Q · filed 2016-07-20 | $3.38M 10-Q · filed 2017-08-10 | $9.94M 10-Q · filed 2016-07-20 | $13.76M derived: sum of 3 quarters · filed 2017-08-10 | $14.64M derived: sum of 4 quarters · filed 2017-08-10 | ||
| 2016-03-31 | $738.00K 10-Q · filed 2017-05-11 | $6.45M 10-Q · filed 2016-05-10 | $11.12M derived: sum of 2 quarters · filed 2017-05-11 | $12.00M derived: sum of 3 quarters · filed 2017-05-11 | $31.50M derived: sum of 4 quarters · filed 2017-05-11 | |||
| 2015-12-31 | $10.38M 10-K · filed 2016-03-15 | $11.26M derived: sum of 2 quarters · filed 2017-03-31 | $30.76M derived: sum of 3 quarters · filed 2017-03-31 | $3.23M 10-K · filed 2017-03-31 | $67.61M 10-K · filed 2016-03-15 | |||
| 2015-09-30 | $880.03K 10-Q/A · filed 2017-03-31 | $17.39M 10-Q · filed 2015-11-05 | $20.38M derived: sum of 2 quarters · filed 2017-03-31 | $2.31M 10-Q/A · filed 2017-03-31 | $57.23M 10-Q · filed 2015-11-05 | $60.61M derived: sum of 4 quarters · filed 2017-03-31 | ||
| 2015-06-30 | $19.50M 10-Q · filed 2016-07-20 | $39.84M 10-Q · filed 2016-07-20 | $59.73M derived: sum of 3 quarters · filed 2016-07-20 | $79.18M derived: sum of 4 quarters · filed 2016-07-20 | ||||
| 2015-03-31 | $20.33M 10-Q · filed 2016-05-10 | $40.23M derived: sum of 2 quarters · filed 2016-05-10 | $59.67M derived: sum of 3 quarters · filed 2016-05-10 | $81.38M derived: sum of 4 quarters · filed 2016-05-10 | ||||
| 2014-12-31 | $19.89M 10-K · filed 2016-03-15 | $39.34M derived: sum of 2 quarters · filed 2016-03-15 | $61.04M derived: sum of 3 quarters · filed 2016-03-15 | $83.95M 10-K · filed 2016-03-15 | ||||
| 2014-09-30 | $19.45M 10-K · filed 2016-03-15 | $41.15M derived: sum of 2 quarters · filed 2016-03-15 | $64.06M 10-Q · filed 2015-11-05 | $87.50M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2014-06-30 | $21.70M 10-K · filed 2016-03-15 | $44.61M 10-Q · filed 2015-08-06 | $68.05M derived: sum of 3 quarters · filed 2016-03-15 | $89.85M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2014-03-31 | $22.91M 10-K · filed 2016-03-15 | $46.35M derived: sum of 2 quarters · filed 2016-03-15 | $68.14M derived: sum of 3 quarters · filed 2016-03-15 | $90.21M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2013-12-31 | $23.44M 10-K · filed 2015-03-12 | $45.24M derived: sum of 2 quarters · filed 2015-03-12 | $67.30M derived: sum of 3 quarters · filed 2015-03-12 | $87.56M 10-K · filed 2016-03-15 | ||||
| 2013-09-30 | $21.79M 10-K · filed 2015-03-12 | $43.86M derived: sum of 2 quarters · filed 2015-03-12 | $64.11M 10-Q · filed 2014-11-06 | $81.82M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-06-30 | $22.06M 10-K · filed 2015-03-12 | $42.32M 10-Q · filed 2014-08-06 | $60.02M derived: sum of 3 quarters · filed 2015-03-12 | $74.56M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-03-31 | $20.26M 10-K · filed 2015-03-12 | $37.96M derived: sum of 2 quarters · filed 2015-03-12 | $52.50M derived: sum of 3 quarters · filed 2015-03-12 | $66.63M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2012-12-31 | $17.70M 10-K · filed 2014-03-11 | $32.24M derived: sum of 2 quarters · filed 2014-03-11 | $46.38M derived: sum of 3 quarters · filed 2014-03-11 | $61.09M 10-K · filed 2015-03-12 | ||||
| 2012-09-30 | $14.54M 10-K · filed 2014-03-11 | $28.67M derived: sum of 2 quarters · filed 2014-03-11 | $43.38M 10-Q · filed 2013-11-04 | $57.05M derived: sum of 4 quarters · filed 2014-03-11 | ||||
| 2012-06-30 | $14.13M 10-K · filed 2014-03-11 | $28.85M 10-Q · filed 2013-08-01 | $42.51M derived: sum of 3 quarters · filed 2014-03-11 | $56.39M derived: sum of 4 quarters · filed 2014-03-11 | ||||
| 2012-03-31 | $14.71M 10-K · filed 2014-03-11 | $28.37M derived: sum of 2 quarters · filed 2014-03-11 | $42.26M derived: sum of 3 quarters · filed 2014-03-11 | $55.62M derived: sum of 4 quarters · filed 2014-03-11 | ||||
| 2011-12-31 | $13.66M 10-K · filed 2013-03-14 | $27.54M derived: sum of 2 quarters · filed 2013-03-14 | $40.91M derived: sum of 3 quarters · filed 2013-03-14 | $53.02M 10-K · filed 2014-03-11 | ||||
| 2011-09-30 | $13.88M 10-K · filed 2013-03-14 | $27.25M derived: sum of 2 quarters · filed 2013-03-14 | $39.35M 10-Q · filed 2012-11-06 | $51.76M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2011-06-30 | $13.36M 10-K · filed 2013-03-14 | $25.47M 10-Q · filed 2012-08-02 | $37.87M derived: sum of 3 quarters · filed 2013-03-14 | $51.49M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2011-03-31 | $12.11M 10-K · filed 2013-03-14 | $24.51M derived: sum of 2 quarters · filed 2013-03-14 | $38.13M derived: sum of 3 quarters · filed 2013-03-14 | $50.53M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2010-12-31 | $12.40M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $26.02M derived: sum of 2 quarters · filed 2013-03-14 | $38.42M derived: sum of 3 quarters · filed 2013-03-14 | $51.70M 10-K · filed 2013-03-14 | ||||
| 2010-09-30 | $13.61M 10-Q · filed 2011-11-03 | $26.02M derived: sum of 2 quarters · filed 2011-11-03 | $39.30M 10-Q · filed 2011-11-03 | |||||
| 2010-06-30 | $12.40M 10-Q · filed 2011-08-04 | $25.68M 10-Q · filed 2011-08-04 | ||||||
| 2009-12-31 | $64.94M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |